Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.24
Delayed Data
As of 11:28am ET
 +0.06 / +5.08%
Today’s Change
1.01
Today|||52-Week Range
2.65
+3.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$89.6M

Company Description

Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Aevi Genomic Medicine, Inc.
435 Devon Park Drive
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:

Employees

Shareholders

Other institutional20.55%
Mutual fund holders2.29%
Individual stakeholders12.69%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
Brian D. PiperChief Financial & Accounting Officer, Secretary
Garry Arthur NeilChief Scientific Officer